The Burden of Medicines
A special issue of Pharmacy (ISSN 2226-4787).
Deadline for manuscript submissions: closed (31 January 2019) | Viewed by 21761
Special Issue Editor
Special Issue Information
Dear Colleagues,
This Special Issue focuses on the burden of medicines on patients’ lives and the role of pharmacists in helping to reduce that burden.
Drug therapy remains to be the most used intervention to prevent illness, reduce symptoms, and treat disease. Unfortunately, medicines are associated with numerous adverse effects that impact on the quality of life and wellbeing of patients. Non-pharmacological approaches to control disease are preferred over drug treatment, but unfortunately these are sometimes insufficient on their own. Patients on multiple drug therapy (polypharmacy) and those with comorbidities are at high risk of drug-related problems. However, pharmacists could help in reducing the burden of drug therapy through the application of pharmaceutical care (PC). With its patient-centred philosophy of practice, the full application of PC should help patients make the best out of their medicines. Given that patients’ perspectives on issues related to the use of medicines are different from those of health care providers, more attention is now drawn toward assessing the burden of drug therapy from the perspective of the patient. That would provide practitioners with information on what health domains are impacted the most, and what intervention should be made to reduce the negative impact of drug therapy.
We invite you to present your research, reviews, or opinions in relation to the burden of medicines and the role of pharmacy and pharmacists in reducing that burden. If you conducted research focusing on PC, health outcomes, patient-reported outcomes, or any related areas, please consider sharing it with readers through this Special Issue of Pharmacy. We wish to increase awareness about the burden of medicines, strategies to assess that burden, and the role of pharmacists in that effort.
Prof. Dr. Nadir Kheir
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmacy is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- medicines
- medications
- burden
- patient-reported outcomes
- quality of life
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.